- Home
- LPSN vs TIL Comparison
LPSN vs TIL Comparison
Compare LPSN & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPSN
- TIL
- Stock Information
- Founded
- LPSN 1995
- TIL 2018
- Country
- LPSN United States
- TIL United States
- Employees
- LPSN N/A
- TIL N/A
- Industry
- LPSN EDP Services
- TIL Biotechnology: Pharmaceutical Preparations
- Sector
- LPSN Technology
- TIL Health Care
- Exchange
- LPSN Nasdaq
- TIL Nasdaq
- Market Cap
- LPSN 122.6M
- TIL 134.5M
- IPO Year
- LPSN 2000
- TIL 2021
- Fundamental
- Price
- LPSN $1.36
- TIL $19.61
- Analyst Decision
- LPSN Hold
- TIL Strong Buy
- Analyst Count
- LPSN 6
- TIL 4
- Target Price
- LPSN $1.18
- TIL $114.00
- AVG Volume (30 Days)
- LPSN 7.8M
- TIL 103.6K
- Earning Date
- LPSN 02-26-2025
- TIL 11-13-2024
- Dividend Yield
- LPSN N/A
- TIL N/A
- EPS Growth
- LPSN N/A
- TIL N/A
- EPS
- LPSN N/A
- TIL N/A
- Revenue
- LPSN $334,736,000.00
- TIL N/A
- Revenue This Year
- LPSN N/A
- TIL N/A
- Revenue Next Year
- LPSN N/A
- TIL $2.64
- P/E Ratio
- LPSN N/A
- TIL N/A
- Revenue Growth
- LPSN N/A
- TIL N/A
- 52 Week Low
- LPSN $0.45
- TIL $9.62
- 52 Week High
- LPSN $3.29
- TIL $92.00
- Technical
- Relative Strength Index (RSI)
- LPSN 57.45
- TIL 42.58
- Support Level
- LPSN $1.27
- TIL $18.56
- Resistance Level
- LPSN $1.43
- TIL $22.00
- Average True Range (ATR)
- LPSN 0.22
- TIL 2.05
- MACD
- LPSN -0.01
- TIL 0.27
- Stochastic Oscillator
- LPSN 33.33
- TIL 13.49
About LPSN LivePerson Inc.
LivePerson Inc is the enterprise leader in digital customer conversation.. The Conversational Cloud, the Company's enterprise-class digital customer conversation platform, is trusted by the world's top brands to accelerate their contact center transformation, orchestrate conversations across all channels, departments and systems, increase agent productivity, and deliver more personalized, AI-empowered customer experiences. The company has a presence in the United Kingdom, Asia-Pacific, Latin America, and Europe.
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.